Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04518800 | PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer | unknown | N/A | 20 | Chinese PLA General HospitalOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT04167007 | FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX(GEMFOX) | unknown | Phase 3 | 400 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 18, 2020 |
| clinicaltrials |
| NCT04517019 | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy(OnkoFit II) | unknown | N/A | 201 | University Hospital TuebingenOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04509687 | Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions(EUS-FNA) | unknown | — | 60 | Changhai HospitalOTHER | 1 | Aug 12, 2020 | clinicaltrials |
| NCT04323917 | Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential | unknown | — | 850 | Istituto Clinico HumanitasOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT04085055 | Fine Needle Biopsy of Solid Pancreatic Mass Lesions | unknown | N/A | 130 | AdventHealthOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT04498689 | Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer | unknown | Phase 2 | 117 | Fudan UniversityOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT03507998 | Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors | unknown | Phase 1 | 39 | Curegenix Inc.INDUSTRY | 1 | Jul 24, 2020 | clinicaltrials |
| NCT04482257 | Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer. | unknown | Phase 1 | 48 | CSPC Ouyi Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04216758 | Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jun 30, 2020 | clinicaltrials |
| NCT04449289 | Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery | unknown | Phase 2 | 100 | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian FodorOTHER | 1 | Jun 26, 2020 | clinicaltrials |
| NCT04440800 | Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment(WATTOX) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 22, 2020 | clinicaltrials |
| NCT02599662 | Intraoperative Radiation Therapy for Resectable Pancreas Cancer(IORT) | unknown | Phase 1 | 12 | Loyola UniversityOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04415385 | The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma | unknown | Phase 2 | 48 | Zhejiang Cancer HospitalOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04387903 | Reoperation After Pancreaticoduodenectomy | unknown | — | 1,000 | Mansoura UniversityOTHER | 0 | May 14, 2020 | clinicaltrials |
| NCT04380506 | Validations of New cut-of for the Stratification of Postoperative Complications,Drains Management(DALCUT) | unknown | N/A | 165 | Campus Bio-Medico UniversityOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT04377048 | Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer | unknown | Phase 2 | 38 | National Taiwan University HospitalOTHER | 0 | May 6, 2020 | clinicaltrials |
| NCT04058236 | Glycocalyx Levels in Patients Undergoing Pancreatectomy | unknown | Phase 4 | 20 | University of MalayaOTHER | 1 | Apr 30, 2020 | clinicaltrials |
| NCT04357483 | Effect of Thrombin-containing Collagen-based Hemostatic Matrix(TCM) | unknown | Phase 4 | 60 | Asan Medical CenterOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04352023 | Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural | unknown | Phase 2 | 110 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 17, 2020 | clinicaltrials |
| NCT04336839 | Portal Vein Resection in Pancreatic Neuroendocrine Tumours(PVNET) | unknown | — | 40 | Royal Free Hospital NHS Foundation TrustOTHER | 0 | Apr 7, 2020 | clinicaltrials |
| NCT04024345 | The Emotional Impact of Surveillance for Pancreatic Cancer | unknown | N/A | 150 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Mar 31, 2020 | clinicaltrials |
| NCT04318756 | The Italian Version of Cancer Worry Scale(CWS_Ita) | unknown | — | 50 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 0 | Mar 24, 2020 | clinicaltrials |
| NCT03850769 | Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT03885219 | Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT02635971 | Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 168 | Fudan UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT03840460 | A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers(PaC-MAn) | unknown | — | 200 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT03167814 | Prevention of Chyle-leak After Major Pancreatic Surgery | unknown | N/A | 96 | Helsinki University Central HospitalOTHER | 1 | Feb 18, 2020 | clinicaltrials |
| NCT04269369 | Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients | unknown | Phase 4 | 250 | Jessa HospitalOTHER | 0 | Feb 13, 2020 | clinicaltrials |
| NCT03882866 | Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer | unknown | N/A | 220 | Ruijin HospitalOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT04239001 | Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer | unknown | N/A | 20 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 23, 2020 | clinicaltrials |
| NCT03544255 | Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues | unknown | — | 50 | Ying LvOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT00526578 | Pancreatic Cancer Genetic Epidemiology (PACGENE) Study | unknown | — | 4,770 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT04217096 | Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients | unknown | Phase 4 | 40 | Fudan UniversityOTHER | 1 | Jan 3, 2020 | clinicaltrials |
| NCT04203459 | The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation | unknown | — | 80 | First Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | Dec 18, 2019 | clinicaltrials |
| NCT03638206 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | unknown | Phase 1 / Phase 2 | 73 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Dec 11, 2019 | clinicaltrials |
| NCT04189393 | Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery(MA-PPING) | unknown | — | 60 | Radboud University Medical CenterOTHER | 0 | Dec 6, 2019 | clinicaltrials |
| NCT04185350 | Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma | unknown | Early Phase 1 | 60 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Dec 4, 2019 | clinicaltrials |
| NCT03838029 | Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery(BC-PC) | unknown | Phase 2 | 210 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Nov 20, 2019 | clinicaltrials |
| NCT03774589 | Bilioenteric Anastomosis by Magnetic Compressive Technique(BAMCT) | unknown | N/A | 200 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT03792048 | Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's Procedure | unknown | N/A | 50 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT04164992 | Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer | unknown | N/A | 15 | Campus Bio-Medico UniversityOTHER | 0 | Nov 18, 2019 | clinicaltrials |
| NCT04164017 | Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions | unknown | N/A | 100 | Centro Hospitalar De São João, E.P.E.OTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT03780946 | Magnetic Compressive Technique for Pancreatic Intestinal Anastomosis(MCTPIA) | unknown | — | 50 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT04158414 | Applying PET/MR in Oncology - a Prospective Project | unknown | N/A | 500 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 8, 2019 | clinicaltrials |
| NCT04101929 | Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen | unknown | Phase 2 | 126 | Fudan UniversityOTHER | 1 | Nov 5, 2019 | clinicaltrials |
| NCT04148755 | The Accurateness of Endoscopic Ultrasound Elastography in the Guidance of EUS-FNA in Solid Pancreatic Lesions | unknown | — | 100 | Assiut UniversityOTHER | 1 | Nov 4, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Aug 19, 2020source: clinicaltrials